NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellectricon

Cellectricon

Private
MölndalHealthcare & Life Scienceshttps://cellectricon.com/

Last Round

VC Round

Feb 21, 2008

Total Funding Raised

$11.87M

Company Overview

Cellectricon is a life sciences company that provides neuroscience drug discovery services intended to decipher disease mechanisms and identify and validate novel targets.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

contract research organizationCROneuroscience drug discoverydrug discovery servicesin-vitro researchneurobiology servicescell-based assaysphenotypic screeningoptical electrophysiologyhigh-content imagingneurotoxicity testingtarget discoverylead optimizationneurodegeneration researchresearch as a servicepharma outsourcingmicrofluidics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellectricon Comparables

Compare Cellectricon with similar companies based on industry and business-model similarity.

Cellectricon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Cellectricon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 21, 2008
Series BMay 26, 2004
Series AJul 11, 2002
View all Funding Rounds

Key People

Founding team and executive leadership

Mattias Karlsson

Chief Executive Officer, Chief Technology Officer

Executive Team

Lotta Agholme

Chief Operating Officer, Laboratory Operations Manager

Executive Team

Cellectricon Investors

Notable investors and investment history

Cellectricon investors
InvestorRounds
Investor Growth CapitalVC Round, Series A, Series B
Karolinska Development ABSeries A, Series B
Dunross & CoVC Round
InnovationsKapital Nordic AdvisorsSeries B
InnovationsKapitalVC Round, Series A
Ägir InvestVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 47% MoM.

  • May 3, 2025

    Monthly visitors increased 85% MoM, reaching 2.4K.

View all signals

Cellectricon Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellectricon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellectricon's valuation, stock price, and market status.

Firmographic Details

HeadquartersMölndal
Employee Range26
Year Founded2003
Last FundingFeb 21, 2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.